Treatment with 5-ASA ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in wild-type mice, but not in whole-body heterozygous Pparg+/− mice (12). This evidence concerns the gene PPARG and colitis.